Mathieu Galibert, PhD – Project Leader in Protein Synthesis will represent GENEPEP at Sixth International Symposium on Antimicrobial Peptides. Come and meet us in Poitiers, France.
Karine Puget, PhD, CEO will be present at RICT 2017 Drug Discovery & Selection in Toulouse, France on 5-7th July 017.
Łukasz Frankiewicz, PhD will represent GENEPEP at 25th American Symposium and present two posters showing our latest work on Total Synthesis of Proteins. Come and meet us in Whistler, BC, Canada.
Mathieu Galibert, PhD – Project Leader in Protein Synthesis will represent GENEPEP at 20th annual GFPP Meeting. We will present two posters showing our latest work on Total Synthesis of Proteins. Come and meet us in Arcachon, France.
Karine Puget, PhD, CEO will be present at Bio-Europe Meeting in Barcelone, Spain on 20-22nd March of 2017.
GENEPEP in collaboration with SERVIER published new publication on Ubiquitine studies. During the project GENEPEP was responsible for the chemical synthesis of the Ubiquitine coupled to different peptidic substrates through side chain of the lysine.
M. Bacchi, B. Fould, M. Jullian, A. Kreiter, A. Maurras, O. Nosjean, T. Coursindel, K. Puget, G. Ferry and J. A. Boutin, Screening ubiquitin specific protease activities using chemically synthesized ubiquitin and ubiquitinated peptides, Anal Biochem, 2017, 519, 57-70.
GENEPEP in collaboration with SERVIER published latest results on Calstabin 2 studies. GENEPEP was responsible for the chemical synthesis of the protein by Native Chemical Ligation (NCL).
M. Bacchi, M. Jullian, S. Sirigu, B. Fould, T. Huet, L. Bruyand, M. Antoine, L. Vuillard, L. Ronga, L. M. Chavas, O. Nosjean, G. Ferry, K. Puget and J. A. Boutin, Total chemical synthesis, refolding, and crystallographic structure of fully active immunophilin calstabin 2 (FKBP12.6), Protein Sci, 2016, 25, 2225-2242.
BCN PEPTIDES and GENEPEP have formed a strategic partnership to extend both companies capabilities towards synthetic peptides process development and manufacturing services on behalf of their clients.